What to expect from GLP-1 side effects and how to manage them well. These articles cover common issues like nausea and digestion, rarer risks worth knowing, and practical steps to stay safe throughout treatment.
Side Effects & Safety
Oral Wegovy brings the weight-loss benefits of semaglutide in pill form, but side effects are still part of the picture. This guide covers what you're likely to feel, what's rare but serious, and practical tips to manage symptoms so you can stay on track.
GLP-1 medications like semaglutide and tirzepatide have helped millions of people lose weight, but they carry risks that don't always make the headlines. This guide breaks down what the science says, what symptoms to watch for, and how to have an informed conversation with your provider before starting or continuing treatment.
New research suggests semaglutide (Ozempic) may work by targeting a previously overlooked region of the brain linked to cravings and compulsive eating. Understanding this mechanism helps explain why GLP-1 medications feel so different from traditional diets. Here's what the science means for patients considering or currently on GLP-1 therapy.
Mounjaro (tirzepatide) is one of the most effective medications available for type 2 diabetes and weight loss, but it comes with real safety considerations that every patient should understand. From drug interactions to kidney health, knowing the risks helps you have a more informed conversation with your provider. Here is what you need to know before your next appointment.
GLP-1 medications like Wegovy, Mounjaro, and Ozempic can cause a range of side effects, from mild nausea to rarer serious complications. This guide covers what to expect, how to manage common symptoms, and red flags that should prompt a call to your doctor.
GLP-1 medications like semaglutide and tirzepatide produce real results, but they also come with a range of side effects that many patients aren't fully prepared for. Real users report everything from dramatic appetite suppression to unexpected emotional shifts. This guide breaks down what the research says, what patients report, and how to manage what you experience.
A recent case of a GLP-1 medication overdose linked to a telehealth provider has raised serious questions about dosing safety and oversight. This article breaks down what went wrong, what warning signs to watch for, and how to protect yourself when using online weight-loss services. Understanding these risks could make a meaningful difference in your care.
Emerging research suggests GLP-1 medications like semaglutide may do more than help with weight loss. Scientists are now investigating whether these drugs could help prevent pulmonary fibrosis, the lung scarring that some COVID survivors develop. Here is what the current evidence shows and what it means for patients.